Next Article in Journal
Heterogeneous Nuclear Ribonucleoproteins A1 and A2 Function in Telomerase-Dependent Maintenance of Telomeres
Next Article in Special Issue
Cucurbitacin D Reprograms Glucose Metabolic Network in Prostate Cancer
Previous Article in Journal
Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model
Previous Article in Special Issue
Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Hiroshi Sugano et al. Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells. Cancers 2018, 10, 386

1
Department of Surgery, The Jikei University School of Medicine, 3-25-8, Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan
2
Division of Gene Therapy, Research Center for Medical Science, The Jikei University School of Medicine, 3-25-8, Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan
3
Division of Medical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan
*
Author to whom correspondence should be addressed.
Cancers 2019, 11(3), 335; https://doi.org/10.3390/cancers11030335
Submission received: 6 March 2019 / Accepted: 6 March 2019 / Published: 8 March 2019
(This article belongs to the Collection Drug Resistance and Novel Therapies in Cancers)
The authors would like to make a correction to their published paper [1].
There was a mistake in the original version of the article in the legend of Figure 1. The data are in vivo data of SW620 cells (Figure 4a) and not in vitro data. The authors wish to replace the 5th sentence in legend of Figure 1 with:
“p65 concentration was higher in the IR groups than in the control groups (SW620: 1067.5 ± 55.9 vs. 440.1 ± 30.5, DLD-1: 1948.5 ± 169.8 vs. 1589.2 ± 115.7; p < 0.01) and decreased in the combination groups (SW620: 731.8 ± 85.0, DLD-1: 899.6 ± 53.7; p < 0.01).”
In addition, there was a mistake on page 4, section 2.2, line 2:
“Three weeks after injection,” should be “Three weeks after treatment,”.
The changes do not affect the scientific results.
The rest of the manuscript does not need to be changed. The authors would like to apologize for any inconvenience caused. The manuscript will be updated, and the original will remain available on the article webpage.

Reference

  1. Sugano, H.; Shirai, Y.; Horiuchi, T.; Saito, N.; Shimada, Y.; Eto, K.; Uwagawa, T.; Ohashi, T.; Yanaga, K. Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells. Cancers 2018, 10, 386. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Sugano, H.; Shirai, Y.; Horiuchi, T.; Saito, N.; Shimada, Y.; Eto, K.; Uwagawa, T.; Ohashi, T.; Yanaga, K. Correction: Hiroshi Sugano et al. Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells. Cancers 2018, 10, 386. Cancers 2019, 11, 335. https://doi.org/10.3390/cancers11030335

AMA Style

Sugano H, Shirai Y, Horiuchi T, Saito N, Shimada Y, Eto K, Uwagawa T, Ohashi T, Yanaga K. Correction: Hiroshi Sugano et al. Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells. Cancers 2018, 10, 386. Cancers. 2019; 11(3):335. https://doi.org/10.3390/cancers11030335

Chicago/Turabian Style

Sugano, Hiroshi, Yoshihiro Shirai, Takashi Horiuchi, Nobuhiro Saito, Yohta Shimada, Ken Eto, Tadashi Uwagawa, Toya Ohashi, and Katsuhiko Yanaga. 2019. "Correction: Hiroshi Sugano et al. Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells. Cancers 2018, 10, 386" Cancers 11, no. 3: 335. https://doi.org/10.3390/cancers11030335

APA Style

Sugano, H., Shirai, Y., Horiuchi, T., Saito, N., Shimada, Y., Eto, K., Uwagawa, T., Ohashi, T., & Yanaga, K. (2019). Correction: Hiroshi Sugano et al. Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells. Cancers 2018, 10, 386. Cancers, 11(3), 335. https://doi.org/10.3390/cancers11030335

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop